PKCα is required for Akt-mTORC1 activation in non-small cell lung carcinoma (NSCLC) with EGFR mutation-Reference-Cited by-同舟云学术

PKCα is required for Akt-mTORC1 activation in non-small cell lung carcinoma (NSCLC) with EGFR mutation

Published:2019-08-16 Issue:48 Volume:38 Page:7311-7328
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Salama Mohamed F.^ORCID,Liu Mengling,Clarke Christopher J.,Espaillat Mel Pilar,Haley John D.,Jin Ting,Wang Daifeng,Obeid Lina M.^ORCID,Hannun Yusuf A.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/s41388-019-0950-z.pdf

Reference52 articles.

1. Kanne JP. Screening for lung cancer: what have we learned? Am J Roentgenol. 2014;202:530–5.

2. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–86.

3. Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA (eds). Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc. 2008;83:584–94.

4. Shames DS, Wistuba II. The evolving genomic classification of lung cancer. J Pathol. 2014;232:121–33.

5. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science. 1991;253:49–53.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PKCα inhibitors promote breast cancer immune evasion by maintaining PD-L1 stability;Acta Pharmaceutica Sinica B;2024-08

2. A cuproptosis score model and prognostic score model can evaluate clinical characteristics and immune microenvironment in NSCLC;Cancer Cell International;2024-02-10

3. Identification of Molecular Subtypes and Prognostic Characteristics of Adrenocortical Carcinoma Based on Unsupervised Clustering;International Journal of Molecular Sciences;2023-10-23

4. Targeting Trop-2 as a Cancer Driver;Journal of Clinical Oncology;2023-10-10

5. Potential implications of protein kinase Cα in pathophysiological conditions and therapeutic interventions;Life Sciences;2023-10